93. Application of Fragment-Based De Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 beta
Park, S.; Shin, Y.; Kim, J.; Hong, S.
J. Med. Chem. 2016, 59, 9018.
92. Pd(II)-Catalyzed Tandem Synthesis of Acenes Using Carboxylic Acids as Traceless Directing Groups
Kim, K.; Vasu, D.; Im. H.; Hong, S.
Angew. Chem. Int. Ed. 2016, 55, 8652.
91. Identification of Lead Small Molecule Inhibitors of Glycogen Synthase Kinase-3 beta Using a Fragment-Linking Strategy
Kim, J.; Moon, Y.; Hong, S.
Bioorg. Med. Chem. Lett. 2016, 26, 5669.
90. HS-173, a Novel PI3K Inhibitor Suppresses EMT and Metastasis in Pancreatic Cancer
Rumman, M.; Jung, K. H.; Fang, Z.; Yan, H. H.; Son, M. K.; Kim, S. J.,; Kim, J.; Park, J. H.; Hong, S.; Hong, S.-S.
ONCOTARGET 2016, 47, 78029.
89. Discovery of Dual Inhibitors for Wild Type and D816V Mutant of c-KIT Kinase through Virtual and Biochemical Screening of Natural Products
Park, H.; Lee, S.; Hong, S.
J. Nat. Prod., 2016, 79, 293.
88. Optimization and Biological Evaluation of Aminopyrimidine-based IkB Kinase b Inhibitors with Potent Anti-inflammatory Effects
Shin, Y.; Lim, S. M.; Yan, H. H.; Jung, S.; Fang, Z.; Jung, K. H.; Hong, S.-S.; Hong, S.
Eur. J. Med. Chem. 2016, 123, 544.
87. Strategies to Overcome Acquired Resistances Conferred by Mutations in the Kinase Domain of EGFR
Lim, S. M.; Jeong, Y.; Hong, S.
Future Med. Chem. 2016, 8, 853.
86. Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through the Structure-Based Virtual Screening
Shin, S.; Mah, S.; Hong, S.*; Park, H.*
J. Chem. Inf. Model. 2016, 56, 802.
85. Unraveling Innate Substrate Control in Site-Selective Palladium-Catalyzed C−H Heterocycle Functionalization
Choi, H.; Min, M; Peng, Q.; Kang, D.; Paton, R. S.; Hong, S.
Chem. Sci. 2016, 7, 3900.
84. Rhodium-Catalyzed Direct C−H Phosphorylation of (Hetero)arenes Suitable for Late-Stage Functionalization
Min, M.; Kang, D.; Jung, S.; Hong, S.
Adv. Synth. Catal., 2016, 358, 1296. (Selected as a VIP Paper by the Editorial Office.)
